Abbott Laboratories of Abbott Park, Ill., has announced that its iFS advanced femtosecond laser has received FDA clearance for use in corneal and cataract surgeries to create bow-shaped or curved arcuate incisions. The fifth generation of IntraLase technology, iFS laser is currently used to create lasik flaps and other corneal incisions. The device allows surgeons to make precise, bladeless arcuate incisions during surgery and to customize each incision. “This is an important step as we look to utilize femtosecond laser technology as a potential standard of care during the cataract procedure,” said Jim Mazzo, senior vice president of Abbott Medical Optics Inc., Abbott’s subsidiary in Santa Ana, Calif.